Application of intravenous immunoglobulin (IVIG) to modulate inflammation in critical COVID-19 – A theoretical perspective

COVID-19 is an airway disease that has affected ~125 million people worldwide, caused by a novel coronavirus termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), spread through respiratory droplets, direct contact, and aerosol transmission. Although most patients presenting with absen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaqinuddin, Ahmed, Ambia, Ayesha Rahman, Elgazzar, Tasnim Atef, AlSaud, Maha bint Mishari, Kashir, Junaid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032597/
https://www.ncbi.nlm.nih.gov/pubmed/33878626
http://dx.doi.org/10.1016/j.mehy.2021.110592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032597/
https://www.ncbi.nlm.nih.gov/pubmed/33878626
http://dx.doi.org/10.1016/j.mehy.2021.110592

Ejemplares similares